Telo Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

Telo Therapeutics General Information

Description

Developer of cancer therapeutics designed to improve survival and well-being in cancer patients who have run out of treatment options. The company's platform leverages a novel precision medicine approach to inhibit cancer cell immortality by targeting an enzyme called telomerase used by cancer cells in the immortalization process, enabling the medical community and patients to improve associated treatment outcomes.

Contact Information

Website
www.telotherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (831)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (831)

Telo Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Telo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Mar-2026 Completed Generating Revenue
5. Later Stage VC 15-Mar-2024 Completed Generating Revenue
4. Later Stage VC 21-Dec-2022 Completed Generating Revenue
3. Seed Round 21-Jun-2021 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
To view Telo Therapeutics’s complete valuation and funding history, request access »

Telo Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Telo Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Telo Therapeutics Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Telo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260015323-A1 Piperidine compounds Pending 15-Jul-2024
WO-2026019666-A1 Piperidine compounds Pending 15-Jul-2024
AU-2021383768-A1 Small molecule compounds and compositions Inactive 19-Nov-2020
AU-2021383768-A9 Small molecule compounds and compositions Inactive 19-Nov-2020
CA-3202720-A1 Small molecule compounds and compositions Pending 19-Nov-2020 C07D211/34
To view Telo Therapeutics’s complete patent history, request access »

Telo Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
UCSF Innovation Ventures Venture Capital Minority
Myeloma Investment Fund Not-For-Profit Venture Capital Minority
Mission Bay Capital Venture Capital Minority
Mission BioCapital Venture Capital Minority
Viva Biotech Corporation Minority
To view Telo Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Telo Therapeutics FAQs

  • When was Telo Therapeutics founded?

    Telo Therapeutics was founded in 2015.

  • Where is Telo Therapeutics headquartered?

    Telo Therapeutics is headquartered in San Francisco, CA.

  • What industry is Telo Therapeutics in?

    Telo Therapeutics’s primary industry is Drug Discovery.

  • Is Telo Therapeutics a private or public company?

    Telo Therapeutics is a Private company.

  • What is Telo Therapeutics’s current revenue?

    The current revenue for Telo Therapeutics is .

  • How much funding has Telo Therapeutics raised over time?

    Telo Therapeutics has raised $5.71M.

  • Who are Telo Therapeutics’s investors?

    UCSF Innovation Ventures, Myeloma Investment Fund, Mission Bay Capital, Mission BioCapital, and Viva Biotech have invested in Telo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process